Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Fuchs

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Plos One|May 20, 2014
Mapping pathological phenotypes in a mouse model of CDKL5 disorderElena Amendola, Yang Zhan, Camilla Mattucci, et al.
Digestive Diseases (Basel, Switzerland)|June 6, 2015
Potential of nor-Ursodeoxycholic Acid in Cholestatic and Metabolic DisordersMichael Trauner, Emina Halilbasic, Thierry Claudel, et al.
Neurobiology of Disease|February 23, 2021
A GABA<sub>B</sub> receptor antagonist rescues functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorderLaura Gennaccaro, Claudia Fuchs, Manuela Loi, et al.
Human Molecular Genetics|February 24, 2018
CDKL5 protein substitution therapy rescues neurological phenotypes of a mouse model of CDKL5 disorderStefania Trazzi, Marianna De Franceschi, Claudia Fuchs, et al.
Molecular Metabolism|April 14, 2023
Carboxylesterase 2a deletion provokes hepatic steatosis and insulin resistance in mice involving impaired diacylglycerol and lysophosphatidylcholine catabolismGabriel Chalhoub, Alina Jamnik, Laura Pajed, et al.
Blood|August 11, 2007
The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signalingPhilipp B Staber, Paul Vesely, Naznin Haq, et al.
Aging and Disease|June 7, 2021
Age-Related Cognitive and Motor Decline in a Mouse Model of CDKL5 Deficiency Disorder is Associated with Increased Neuronal Senescence and DeathLaura Gennaccaro, Claudia Fuchs, Manuela Loi, et al.
Cancer Management and Research|March 6, 2025
Drug Repurposing in Pancreatic Cancer: A Multi-Stakeholder Perspective to Improve Treatment Options for Pancreatic Cancer PatientsEvelyn Hewitt, Gauthier Bouche, Alexandre Costa Alencar, et al.
BMC Cancer|September 19, 2024
Randomized phase 2 study of valproic acid combined with simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic pancreatic adenocarcinoma patients: the VESPA trial study protocolAlfredo Budillon, Alessandra Leone, Eugenia Passaro, et al.
Hepatology (Baltimore, Md.)|September 20, 2018
Fine-Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver DiseaseBritt A Blokker, Monica Maijo, Marta Echeandia, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Plos One|May 20, 2014
Mapping pathological phenotypes in a mouse model of CDKL5 disorderElena Amendola, Yang Zhan, Camilla Mattucci, et al.
Digestive Diseases (Basel, Switzerland)|June 6, 2015
Potential of nor-Ursodeoxycholic Acid in Cholestatic and Metabolic DisordersMichael Trauner, Emina Halilbasic, Thierry Claudel, et al.
Neurobiology of Disease|February 23, 2021
A GABA<sub>B</sub> receptor antagonist rescues functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorderLaura Gennaccaro, Claudia Fuchs, Manuela Loi, et al.
Human Molecular Genetics|February 24, 2018
CDKL5 protein substitution therapy rescues neurological phenotypes of a mouse model of CDKL5 disorderStefania Trazzi, Marianna De Franceschi, Claudia Fuchs, et al.
Molecular Metabolism|April 14, 2023
Carboxylesterase 2a deletion provokes hepatic steatosis and insulin resistance in mice involving impaired diacylglycerol and lysophosphatidylcholine catabolismGabriel Chalhoub, Alina Jamnik, Laura Pajed, et al.
Blood|August 11, 2007
The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signalingPhilipp B Staber, Paul Vesely, Naznin Haq, et al.
Aging and Disease|June 7, 2021
Age-Related Cognitive and Motor Decline in a Mouse Model of CDKL5 Deficiency Disorder is Associated with Increased Neuronal Senescence and DeathLaura Gennaccaro, Claudia Fuchs, Manuela Loi, et al.
Cancer Management and Research|March 6, 2025
Drug Repurposing in Pancreatic Cancer: A Multi-Stakeholder Perspective to Improve Treatment Options for Pancreatic Cancer PatientsEvelyn Hewitt, Gauthier Bouche, Alexandre Costa Alencar, et al.
BMC Cancer|September 19, 2024
Randomized phase 2 study of valproic acid combined with simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic pancreatic adenocarcinoma patients: the VESPA trial study protocolAlfredo Budillon, Alessandra Leone, Eugenia Passaro, et al.
Hepatology (Baltimore, Md.)|September 20, 2018
Fine-Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver DiseaseBritt A Blokker, Monica Maijo, Marta Echeandia, et al.
Pageof 5